Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 171

1.

Renal Cell Carcinoma Presenting as an Ampullary Mass: A Case Report and Review of Literature.

Hasan S, Khan Z, Khan MS, Darr U, Javaid T, Ahmed R, Nawras A.

Gastroenterology Res. 2018 Jun;11(3):231-234. doi: 10.14740/gr981w. Epub 2018 May 31.

2.

A Rare Case of Metastasis to the Thyroid Gland from Renal Clear Cell Carcinoma 11 Years after Nephrectomy and Concurrent Primary Esophageal Carcinoma.

Khan MS, Iyer VB, Varshney N.

Case Rep Oncol Med. 2018 Apr 2;2018:3790106. doi: 10.1155/2018/3790106. eCollection 2018.

3.

Endogenous H2S producing enzymes are involved in apoptosis induction in clear cell renal cell carcinoma.

Breza J Jr, Soltysova A, Hudecova S, Penesova A, Szadvari I, Babula P, Chovancova B, Lencesova L, Pos O, Breza J, Ondrias K, Krizanova O.

BMC Cancer. 2018 May 24;18(1):591. doi: 10.1186/s12885-018-4508-1.

4.

VHL status regulates transforming growth factor-β signaling pathways in renal cell carcinoma.

Mallikarjuna P, Sitaram RT, Landström M, Ljungberg B.

Oncotarget. 2018 Mar 27;9(23):16297-16310. doi: 10.18632/oncotarget.24631. eCollection 2018 Mar 27.

5.

Outcomes of pathologic stage T3a renal cell carcinoma up-staged from small renal tumor: emphasis on partial nephrectomy.

Lee H, Lee M, Lee SE, Byun SS, Kim HH, Kwak C, Hong SK.

BMC Cancer. 2018 Apr 16;18(1):427. doi: 10.1186/s12885-018-4338-1.

6.

PAN-cancer analysis of S-phase enriched lncRNAs identifies oncogenic drivers and biomarkers.

Ali MM, Akhade VS, Kosalai ST, Subhash S, Statello L, Meryet-Figuiere M, Abrahamsson J, Mondal T, Kanduri C.

Nat Commun. 2018 Feb 28;9(1):883. doi: 10.1038/s41467-018-03265-1.

7.

Renal capsular invasion is a prognostic biomarker in localized clear cell renal cell carcinoma.

Ha US, Lee KW, Jung JH, Byun SS, Kwak C, Chung J, Hwang EC, Kim YJ, Kwon TG, Kang SH, Hong SH.

Sci Rep. 2018 Jan 9;8(1):202. doi: 10.1038/s41598-017-18466-9. Erratum in: Sci Rep. 2018 May 11;8(1):7633.

8.

GIMDA: Graphlet interaction-based MiRNA-disease association prediction.

Chen X, Guan NN, Li JQ, Yan GY.

J Cell Mol Med. 2018 Mar;22(3):1548-1561. doi: 10.1111/jcmm.13429. Epub 2017 Dec 22.

9.

Overexpression of CAPN2 promotes cell metastasis and proliferation via AKT/mTOR signaling in renal cell carcinoma.

Miao C, Liang C, Tian Y, Xu A, Zhu J, Zhao K, Zhang J, Hua Y, Liu S, Dong H, Zhang C, Su S, Li P, Qin C, Wang Z.

Oncotarget. 2017 Oct 26;8(58):97811-97821. doi: 10.18632/oncotarget.22083. eCollection 2017 Nov 17.

10.

Sarcomatoid renal cell carcinoma: genomic insights from sequencing of matched sarcomatous and carcinomatous components.

Manley BJ, Hsieh JJ.

Transl Cancer Res. 2016 Aug;5(Suppl 2):S160-S165. doi: 10.21037/tcr.2016.07.30. No abstract available.

11.

Combination of mTOR and MAPK Inhibitors-A Potential Way to Treat Renal Cell Carcinoma.

Chauhan A, Semwal DK, Mishra SP, Goyal S, Marathe R, Semwal RB.

Med Sci (Basel). 2016 Oct 17;4(4). pii: E16. doi: 10.3390/medsci4040016. Review.

12.

Outcome of papillary versus clear cell renal cell carcinoma varies significantly in non-metastatic disease.

Wagener N, Edelmann D, Benner A, Zigeuner R, Borgmann H, Wolff I, Krabbe LM, Musquera M, Dell'Oglio P, Capitanio U, Klatte T, Cindolo L, May M, Brookman-May SD; European Association of Urology (EAU) Young Academic Urologists (YAU) Kidney Cancer Group.

PLoS One. 2017 Sep 21;12(9):e0184173. doi: 10.1371/journal.pone.0184173. eCollection 2017.

13.

Preoperative cholesterol level as a new independent predictive factor of survival in patients with metastatic renal cell carcinoma treated with cyto-reductive nephrectomy.

Lee H, Kim YJ, Hwang EC, Kang SH, Hong SH, Chung J, Kwon TG, Kwak C, Kim HH, Oh JJ, Lee SC, Hong SK, Lee SE, Byun SS; KOrean Renal Cell Carcinoma (KORCC) Group.

BMC Cancer. 2017 May 25;17(1):364. doi: 10.1186/s12885-017-3322-5.

14.

Stratification of clear cell renal cell carcinoma (ccRCC) genomes by gene-directed copy number alteration (CNA) analysis.

Thiesen HJ, Steinbeck F, Maruschke M, Koczan D, Ziems B, Hakenberg OW.

PLoS One. 2017 May 9;12(5):e0176659. doi: 10.1371/journal.pone.0176659. eCollection 2017.

15.

Visual evaluation and differentiation of renal oncocytomas from renal cell carcinomas by means of 99mTc-sestamibi SPECT/CT.

Tzortzakakis A, Gustafsson O, Karlsson M, Ekström-Ehn L, Ghaffarpour R, Axelsson R.

EJNMMI Res. 2017 Dec;7(1):29. doi: 10.1186/s13550-017-0278-z. Epub 2017 Mar 29.

16.

Unusual Case of Coexisting Renal Malignancies: Mucinous Tubular and Spindle Cell Carcinoma Kidney With Sarcomatoid Dedifferentiation.

Akhtar K, Agnihotri P, Alam K, Raza K.

J Kidney Cancer VHL. 2016 May 31;3(2):8-13. doi: 10.15586/jkcvhl.2016.51. eCollection 2016.

17.

The ISUP system of staging, grading and classification of renal cell neoplasia.

Samaratunga H, Gianduzzo T, Delahunt B.

J Kidney Cancer VHL. 2014 Jul 20;1(3):26-39. doi: 10.15586/jkcvhl.2014.11. eCollection 2014.

18.

Renal cell carcinoma.

Hsieh JJ, Purdue MP, Signoretti S, Swanton C, Albiges L, Schmidinger M, Heng DY, Larkin J, Ficarra V.

Nat Rev Dis Primers. 2017 Mar 9;3:17009. doi: 10.1038/nrdp.2017.9. Review.

19.

Benefit of adjuvant immunotherapy in renal cell carcinoma: A myth or a reality?

Taguchi S, Buti S, Fukuhara H, Otsuka M, Bersanelli M, Morikawa T, Miyazaki H, Nakagawa T, Fujimura T, Kume H, Igawa Y, Homma Y.

PLoS One. 2017 Feb 27;12(2):e0172341. doi: 10.1371/journal.pone.0172341. eCollection 2017.

20.

An association between overexpression of DNA methyltransferase 3B4 and clear cell renal cell carcinoma.

Liu Y, Sun L, Fong P, Yang J, Zhang Z, Yin S, Jiang S, Liu X, Ju H, Huang L, Bai J, Gong K, Yan S, Zhang C, Shao G.

Oncotarget. 2017 Mar 21;8(12):19712-19722. doi: 10.18632/oncotarget.14966.

Supplemental Content

Support Center